 a 2007 purchase of medicines from merck kgaa , drugmaker mylan picked up a decades-old product , the epipen auto injector for food allergy and bee-sting emergencies . newline_char that started epipen , which delivers about $ 1 worth of the hormone epinephrine , on a run that ’ s resulted in its becoming a $ 1 billion-a-year product that clobbers its rivals and provides about 40 percent of mylan ’ s operating profits , says researcher abr|healthco . newline_char along the way , epipen ’ s wholesale price rose roughly 400 percent from about $ 57 each when mylan acquired the product . newline_char but while epipen has given countless parents a sense of security that their children can go out in the world safely , the device ’ s soaring price—up 32 percent in the past year alone—has forced some families to make difficult choices in order to afford the life-saving medicine . story_separator_special_tag doctors and patients say the mylan pharmaceutical company has jacked up the prices for an epipen — the portable device that can stop a potentially life-threatening allergic reaction — from around $ 100 in 2008 to $ 500 and up today . newline_char mylan did n't invent the epipen , it acquired it in 2007 , getting a drug that had been approved since 1987 and had 90 percent market dominance . story_separator_special_tag families with severe allergies often rely on epipens to deliver a dose of potentially life-saving medicine if a child has a bad reaction . newline_char the epipen is filled with epinephrine , which can counter the effects of a severe allergic reaction . newline_char of the family 's six children , two have severe food allergies : 3-year-old cora and 7-year-old ellie . newline_char her family has twice used the epipen to save her life .
